🟢 Beam Therapeutics is trading 10.1% up today as biotech shares rally

Beam Therapeutics is trading at $31.20 (+10.13%) as biotechnology shares rally, with XBI up 2.06% during the regular session.

• No fresh company-specific announcement, earnings release, FDA action, or analyst event was identified for August 25, 2026.
• Sector momentum follows strong recent biotechnology sentiment and ongoing optimism around clinical breakthroughs and industry activity.
• The move appears primarily sector-driven rather than company-specific.